retatrutide clinical trial obesity What is ongoing research showing about the weight loss treatment, retatrutide? In a recent update on Eli Lilly's Phase 3 studies investigating retatrutide, which is a GIP, GLP-1, and glucagon triple-hormone Meal Replacement Shake Weight Watchers GLP-1 Med+ Count:30

retatrutide clinical trial obesity What is ongoing research showing about the weight loss treatment, retatrutide? In a recent update on Eli Lilly's Phase 3 studies investigating retatrutide, which is a GIP, GLP-1, and glucagon triple-hormone Meal Replacement Shake Weight Watchers GLP-1 Med+ Count:30

Weight Watchers GLP-1 Med+ Review (2026) – Forbes Health

For example, select patients in the cohort did not identify their race but instead only chose to identify their ethnicity

Meal Replacement Shake

Count:30

For the Australian framework governing research-grade peptide supply, see the Research Peptides Legal Status guide